Injectable GHK-Cu provides systemic delivery with higher bioavailability than topical products
What it offers is a mechanism that addresses the root causes of weight retention, not just the symptoms, and a protocol built around making that process as tolerable and sustainable as possible
avoidance recommended as a precaution Active malignancy: Pro-angiogenic mechanism warrants caution until more data is available History of hormone-sensitive cancers: Discuss thoroughly with your physician Severe coagulation disorders: Given vascular effects, clinical assessment required Patients on certain anticoagulants: Monitoring required
Understanding GLP-1 Drugs and Weight Loss GLP-1 (glucagon-like peptide-1) analogs work by mimicking the bodys natural hormone that regulates appetite, insulin response, and glucose metabolism
Conrotto P, Corso S, Gamberini S, Comoglio PM, Giordano S
Krejci, L., Altmannova, V., Spirek, M